Research & Development



  “我剛剛成親啊……自然需要補一下。”   宋喬又穿上一片甲冑,用絲線牢牢地將甲片固定在厚厚的褙子上,然後低聲道︰“夫君已經給我留遺言了。”免费1级做爰片在线观看   “這就對了,算學是西北理工學說中最基礎的一門學科,你現在學的連皮毛都算不上。小子,你至少要學十六年才能對西北理工的學說有一個大概的認知。”国产在线自天天人人   即便是雲瑯跟霍去病都不知道他什麼時候成的親……   長平搖搖頭,她還是堅信雲瑯是一個有些小聰明的小子,絕對不是衛青口中的老奸巨猾之輩。青草在线在线d青草在线   雲瑯這才松了一口氣。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo